nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.176	0.242	CbGbCtD
Methoxsalen—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.151	0.207	CbGbCtD
Methoxsalen—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.13	0.178	CbGbCtD
Methoxsalen—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0725	0.0992	CbGbCtD
Methoxsalen—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0579	0.0793	CbGbCtD
Methoxsalen—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.038	0.052	CbGbCtD
Methoxsalen—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0353	0.0483	CbGbCtD
Methoxsalen—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0283	0.0388	CbGbCtD
Methoxsalen—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0162	0.0222	CbGbCtD
Methoxsalen—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0148	0.0203	CbGbCtD
Methoxsalen—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0101	0.0139	CbGbCtD
Methoxsalen—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.000979	0.00363	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.000979	0.00363	CcSEcCtD
Methoxsalen—Skin exfoliation—Etoposide—peripheral nervous system neoplasm	0.000966	0.00358	CcSEcCtD
Methoxsalen—Depression—Isotretinoin—peripheral nervous system neoplasm	0.000954	0.00353	CcSEcCtD
Methoxsalen—Depression—Tretinoin—peripheral nervous system neoplasm	0.000954	0.00353	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Epirubicin—peripheral nervous system neoplasm	0.000954	0.00353	CcSEcCtD
Methoxsalen—Folliculitis—Epirubicin—peripheral nervous system neoplasm	0.000902	0.00334	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Doxorubicin—peripheral nervous system neoplasm	0.000882	0.00327	CcSEcCtD
Methoxsalen—Dry skin—Alitretinoin—peripheral nervous system neoplasm	0.000862	0.0032	CcSEcCtD
Methoxsalen—Redness—Epirubicin—peripheral nervous system neoplasm	0.00084	0.00311	CcSEcCtD
Methoxsalen—Folliculitis—Doxorubicin—peripheral nervous system neoplasm	0.000835	0.00309	CcSEcCtD
Methoxsalen—Blister—Epirubicin—peripheral nervous system neoplasm	0.000787	0.00292	CcSEcCtD
Methoxsalen—Redness—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.00288	CcSEcCtD
Methoxsalen—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000767	0.00284	CcSEcCtD
Methoxsalen—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000767	0.00284	CcSEcCtD
Methoxsalen—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.000757	0.00281	CcSEcCtD
Methoxsalen—Erythema—Tretinoin—peripheral nervous system neoplasm	0.000748	0.00277	CcSEcCtD
Methoxsalen—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.000748	0.00277	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.000742	0.00275	CcSEcCtD
Methoxsalen—Tension—Tretinoin—peripheral nervous system neoplasm	0.000734	0.00272	CcSEcCtD
Methoxsalen—Tension—Isotretinoin—peripheral nervous system neoplasm	0.000734	0.00272	CcSEcCtD
Methoxsalen—Blister—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.0027	CcSEcCtD
Methoxsalen—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.000726	0.00269	CcSEcCtD
Methoxsalen—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.000726	0.00269	CcSEcCtD
Methoxsalen—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.000725	0.00268	CcSEcCtD
Methoxsalen—Depression—Alitretinoin—peripheral nervous system neoplasm	0.000723	0.00268	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.000715	0.00265	CcSEcCtD
Methoxsalen—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.000699	0.00259	CcSEcCtD
Methoxsalen—Depression—Vincristine—peripheral nervous system neoplasm	0.000697	0.00258	CcSEcCtD
Methoxsalen—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.000694	0.00257	CcSEcCtD
Methoxsalen—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.000694	0.00257	CcSEcCtD
Methoxsalen—Malaise—Topotecan—peripheral nervous system neoplasm	0.00068	0.00252	CcSEcCtD
Methoxsalen—Malaise—Tretinoin—peripheral nervous system neoplasm	0.000674	0.0025	CcSEcCtD
Methoxsalen—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.000674	0.0025	CcSEcCtD
Methoxsalen—Discomfort—Topotecan—peripheral nervous system neoplasm	0.000634	0.00235	CcSEcCtD
Methoxsalen—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000629	0.00233	CcSEcCtD
Methoxsalen—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.000629	0.00233	CcSEcCtD
Methoxsalen—Herpes simplex—Epirubicin—peripheral nervous system neoplasm	0.000615	0.00228	CcSEcCtD
Methoxsalen—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000611	0.00226	CcSEcCtD
Methoxsalen—Infection—Topotecan—peripheral nervous system neoplasm	0.000611	0.00226	CcSEcCtD
Methoxsalen—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00061	0.00226	CcSEcCtD
Methoxsalen—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00061	0.00226	CcSEcCtD
Methoxsalen—Infection—Tretinoin—peripheral nervous system neoplasm	0.000606	0.00225	CcSEcCtD
Methoxsalen—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000606	0.00225	CcSEcCtD
Methoxsalen—Oedema—Melphalan—peripheral nervous system neoplasm	0.000602	0.00223	CcSEcCtD
Methoxsalen—Infection—Melphalan—peripheral nervous system neoplasm	0.000598	0.00222	CcSEcCtD
Methoxsalen—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000597	0.00221	CcSEcCtD
Methoxsalen—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000593	0.0022	CcSEcCtD
Methoxsalen—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000593	0.0022	CcSEcCtD
Methoxsalen—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000585	0.00217	CcSEcCtD
Methoxsalen—Inflammation—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00217	CcSEcCtD
Methoxsalen—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000581	0.00215	CcSEcCtD
Methoxsalen—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00057	0.00211	CcSEcCtD
Methoxsalen—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00057	0.00211	CcSEcCtD
Methoxsalen—Herpes simplex—Doxorubicin—peripheral nervous system neoplasm	0.000569	0.00211	CcSEcCtD
Methoxsalen—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.000567	0.0021	CcSEcCtD
Methoxsalen—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000567	0.0021	CcSEcCtD
Methoxsalen—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000563	0.00209	CcSEcCtD
Methoxsalen—Tension—Alitretinoin—peripheral nervous system neoplasm	0.000556	0.00206	CcSEcCtD
Methoxsalen—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000552	0.00204	CcSEcCtD
Methoxsalen—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000552	0.00204	CcSEcCtD
Methoxsalen—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.000551	0.00204	CcSEcCtD
Methoxsalen—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00204	CcSEcCtD
Methoxsalen—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.000541	0.00201	CcSEcCtD
Methoxsalen—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000541	0.00201	CcSEcCtD
Methoxsalen—Inflammation—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.002	CcSEcCtD
Methoxsalen—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000537	0.00199	CcSEcCtD
Methoxsalen—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000537	0.00199	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000531	0.00197	CcSEcCtD
Methoxsalen—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00053	0.00196	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000527	0.00195	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000527	0.00195	CcSEcCtD
Methoxsalen—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000526	0.00195	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Epirubicin—peripheral nervous system neoplasm	0.000521	0.00193	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00052	0.00193	CcSEcCtD
Methoxsalen—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000514	0.0019	CcSEcCtD
Methoxsalen—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000511	0.00189	CcSEcCtD
Methoxsalen—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000507	0.00188	CcSEcCtD
Methoxsalen—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000503	0.00186	CcSEcCtD
Methoxsalen—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000503	0.00186	CcSEcCtD
Methoxsalen—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.00186	CcSEcCtD
Methoxsalen—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000499	0.00185	CcSEcCtD
Methoxsalen—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000496	0.00184	CcSEcCtD
Methoxsalen—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000495	0.00184	CcSEcCtD
Methoxsalen—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000491	0.00182	CcSEcCtD
Methoxsalen—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000489	0.00181	CcSEcCtD
Methoxsalen—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000486	0.0018	CcSEcCtD
Methoxsalen—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000485	0.0018	CcSEcCtD
Methoxsalen—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000485	0.0018	CcSEcCtD
Methoxsalen—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000483	0.00179	CcSEcCtD
Methoxsalen—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000482	0.00179	CcSEcCtD
Methoxsalen—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000482	0.00179	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.00179	CcSEcCtD
Methoxsalen—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000478	0.00177	CcSEcCtD
Methoxsalen—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000477	0.00177	CcSEcCtD
Methoxsalen—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000464	0.00172	CcSEcCtD
Methoxsalen—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00171	CcSEcCtD
Methoxsalen—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.0017	CcSEcCtD
Methoxsalen—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000453	0.00168	CcSEcCtD
Methoxsalen—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00045	0.00167	CcSEcCtD
Methoxsalen—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00045	0.00167	CcSEcCtD
Methoxsalen—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.00166	CcSEcCtD
Methoxsalen—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000448	0.00166	CcSEcCtD
Methoxsalen—Oedema—Vincristine—peripheral nervous system neoplasm	0.000446	0.00165	CcSEcCtD
Methoxsalen—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000444	0.00164	CcSEcCtD
Methoxsalen—Infection—Vincristine—peripheral nervous system neoplasm	0.000443	0.00164	CcSEcCtD
Methoxsalen—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000435	0.00161	CcSEcCtD
Methoxsalen—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000435	0.00161	CcSEcCtD
Methoxsalen—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000433	0.0016	CcSEcCtD
Methoxsalen—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000432	0.0016	CcSEcCtD
Methoxsalen—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000432	0.0016	CcSEcCtD
Methoxsalen—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000432	0.0016	CcSEcCtD
Methoxsalen—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000431	0.0016	CcSEcCtD
Methoxsalen—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000426	0.00158	CcSEcCtD
Methoxsalen—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000425	0.00158	CcSEcCtD
Methoxsalen—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000418	0.00155	CcSEcCtD
Methoxsalen—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000416	0.00154	CcSEcCtD
Methoxsalen—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000411	0.00152	CcSEcCtD
Methoxsalen—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00041	0.00152	CcSEcCtD
Methoxsalen—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.00151	CcSEcCtD
Methoxsalen—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000407	0.00151	CcSEcCtD
Methoxsalen—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000406	0.0015	CcSEcCtD
Methoxsalen—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000404	0.0015	CcSEcCtD
Methoxsalen—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000404	0.0015	CcSEcCtD
Methoxsalen—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000403	0.00149	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.00148	CcSEcCtD
Methoxsalen—Malaise—Etoposide—peripheral nervous system neoplasm	0.000399	0.00148	CcSEcCtD
Methoxsalen—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00148	CcSEcCtD
Methoxsalen—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000397	0.00147	CcSEcCtD
Methoxsalen—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000394	0.00146	CcSEcCtD
Methoxsalen—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000394	0.00146	CcSEcCtD
Methoxsalen—Infection—Cisplatin—peripheral nervous system neoplasm	0.000391	0.00145	CcSEcCtD
Methoxsalen—Rash—Topotecan—peripheral nervous system neoplasm	0.000388	0.00144	CcSEcCtD
Methoxsalen—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000387	0.00144	CcSEcCtD
Methoxsalen—Headache—Topotecan—peripheral nervous system neoplasm	0.000385	0.00143	CcSEcCtD
Methoxsalen—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000385	0.00143	CcSEcCtD
Methoxsalen—Rash—Tretinoin—peripheral nervous system neoplasm	0.000385	0.00143	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000385	0.00143	CcSEcCtD
Methoxsalen—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000384	0.00142	CcSEcCtD
Methoxsalen—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000384	0.00142	CcSEcCtD
Methoxsalen—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00142	CcSEcCtD
Methoxsalen—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000382	0.00142	CcSEcCtD
Methoxsalen—Headache—Tretinoin—peripheral nervous system neoplasm	0.000382	0.00142	CcSEcCtD
Methoxsalen—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00141	CcSEcCtD
Methoxsalen—Rash—Melphalan—peripheral nervous system neoplasm	0.00038	0.00141	CcSEcCtD
Methoxsalen—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000379	0.00141	CcSEcCtD
Methoxsalen—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000377	0.0014	CcSEcCtD
Methoxsalen—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000372	0.00138	CcSEcCtD
Methoxsalen—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000368	0.00136	CcSEcCtD
Methoxsalen—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000367	0.00136	CcSEcCtD
Methoxsalen—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.00136	CcSEcCtD
Methoxsalen—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000366	0.00135	CcSEcCtD
Methoxsalen—Nausea—Topotecan—peripheral nervous system neoplasm	0.000365	0.00135	CcSEcCtD
Methoxsalen—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000362	0.00134	CcSEcCtD
Methoxsalen—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000362	0.00134	CcSEcCtD
Methoxsalen—Infection—Etoposide—peripheral nervous system neoplasm	0.000359	0.00133	CcSEcCtD
Methoxsalen—Nausea—Melphalan—peripheral nervous system neoplasm	0.000358	0.00133	CcSEcCtD
Methoxsalen—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000352	0.00131	CcSEcCtD
Methoxsalen—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000351	0.0013	CcSEcCtD
Methoxsalen—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.00129	CcSEcCtD
Methoxsalen—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000341	0.00126	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00034	0.00126	CcSEcCtD
Methoxsalen—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000337	0.00125	CcSEcCtD
Methoxsalen—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000328	0.00122	CcSEcCtD
Methoxsalen—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.00121	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000325	0.0012	CcSEcCtD
Methoxsalen—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000325	0.0012	CcSEcCtD
Methoxsalen—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000314	0.00117	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000312	0.00115	CcSEcCtD
Methoxsalen—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000311	0.00115	CcSEcCtD
Methoxsalen—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00113	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.00111	CcSEcCtD
Methoxsalen—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000297	0.0011	CcSEcCtD
Methoxsalen—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000296	0.0011	CcSEcCtD
Methoxsalen—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000295	0.00109	CcSEcCtD
Methoxsalen—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00108	CcSEcCtD
Methoxsalen—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.00108	CcSEcCtD
Methoxsalen—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00029	0.00108	CcSEcCtD
Methoxsalen—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00107	CcSEcCtD
Methoxsalen—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000287	0.00106	CcSEcCtD
Methoxsalen—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000285	0.00106	CcSEcCtD
Methoxsalen—Rash—Vincristine—peripheral nervous system neoplasm	0.000281	0.00104	CcSEcCtD
Methoxsalen—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000281	0.00104	CcSEcCtD
Methoxsalen—Headache—Vincristine—peripheral nervous system neoplasm	0.000279	0.00103	CcSEcCtD
Methoxsalen—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.00102	CcSEcCtD
Methoxsalen—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000266	0.000985	CcSEcCtD
Methoxsalen—Nausea—Vincristine—peripheral nervous system neoplasm	0.000265	0.000981	CcSEcCtD
Methoxsalen—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000255	0.000946	CcSEcCtD
Methoxsalen—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000943	CcSEcCtD
Methoxsalen—Rash—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00092	CcSEcCtD
Methoxsalen—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00092	CcSEcCtD
Methoxsalen—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000919	CcSEcCtD
Methoxsalen—Tension—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000901	CcSEcCtD
Methoxsalen—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000243	0.0009	CcSEcCtD
Methoxsalen—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000892	CcSEcCtD
Methoxsalen—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000239	0.000884	CcSEcCtD
Methoxsalen—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000883	CcSEcCtD
Methoxsalen—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000872	CcSEcCtD
Methoxsalen—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000234	0.000867	CcSEcCtD
Methoxsalen—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000852	CcSEcCtD
Methoxsalen—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.00085	CcSEcCtD
Methoxsalen—Rash—Etoposide—peripheral nervous system neoplasm	0.000228	0.000843	CcSEcCtD
Methoxsalen—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000227	0.000842	CcSEcCtD
Methoxsalen—Headache—Etoposide—peripheral nervous system neoplasm	0.000226	0.000838	CcSEcCtD
Methoxsalen—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000834	CcSEcCtD
Methoxsalen—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000832	CcSEcCtD
Methoxsalen—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000828	CcSEcCtD
Methoxsalen—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000826	CcSEcCtD
Methoxsalen—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000825	CcSEcCtD
Methoxsalen—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000817	CcSEcCtD
Methoxsalen—Nausea—Etoposide—peripheral nervous system neoplasm	0.000214	0.000794	CcSEcCtD
Methoxsalen—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000789	CcSEcCtD
Methoxsalen—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000773	CcSEcCtD
Methoxsalen—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000766	CcSEcCtD
Methoxsalen—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000764	CcSEcCtD
Methoxsalen—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00075	CcSEcCtD
Methoxsalen—Infection—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000745	CcSEcCtD
Methoxsalen—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000728	CcSEcCtD
Methoxsalen—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000715	CcSEcCtD
Methoxsalen—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000701	CcSEcCtD
Methoxsalen—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000694	CcSEcCtD
Methoxsalen—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000689	CcSEcCtD
Methoxsalen—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000678	CcSEcCtD
Methoxsalen—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000674	CcSEcCtD
Methoxsalen—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00066	CcSEcCtD
Methoxsalen—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000648	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000647	CcSEcCtD
Methoxsalen—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000627	CcSEcCtD
Methoxsalen—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000618	CcSEcCtD
Methoxsalen—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000611	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000599	CcSEcCtD
Methoxsalen—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000596	CcSEcCtD
Methoxsalen—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000593	CcSEcCtD
Methoxsalen—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000572	CcSEcCtD
Methoxsalen—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000552	CcSEcCtD
Methoxsalen—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000551	CcSEcCtD
Methoxsalen—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000548	CcSEcCtD
Methoxsalen—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00053	CcSEcCtD
Methoxsalen—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000511	CcSEcCtD
Methoxsalen—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000496	CcSEcCtD
Methoxsalen—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000491	CcSEcCtD
Methoxsalen—Rash—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000473	CcSEcCtD
Methoxsalen—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000472	CcSEcCtD
Methoxsalen—Headache—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00047	CcSEcCtD
Methoxsalen—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000459	CcSEcCtD
Methoxsalen—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000445	CcSEcCtD
Methoxsalen—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000437	CcSEcCtD
Methoxsalen—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000437	CcSEcCtD
Methoxsalen—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000435	CcSEcCtD
Methoxsalen—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000412	CcSEcCtD
